Results for gilead: 16

In tough times, technology industry leaders are showing how it's possible to thrive鈥攁nd winning slots in BW's annual Tech Hot Growth ranking

* ViiV Healthcare launched, pooling Glaxo and Pfizer drugs * CEO hopes to overtake Gilead, sees Selzentry as key driver LONDON, Nov 3 - GlaxoSmithKline, working alongside Pfizer in an unusual collaboration, aims to regain...

WASHINGTON, March 5 - A Gilead Sciences Inc representative made misleading statements about the company's Letairis drug for pulmonary arterial hypertension at a conference last year, U.S. regulators said in a letter made public on...

LOS ANGELES, Oct 16 - Gilead Sciences Inc on Thursday said it still expects 2008 drug sales of $4.9 billion to $5.0 billion, while noting that changes in foreign exchange rates could affect the total....

NEW YORK, April 22 - U.S. stocks rose on Wednesday, with the Nasdaq up 2 percent, as investors bet that Apple Inc would post strong results after the closing bell, lifting the technology sector. *...

* Caterpillar rises after upgrade * Boeing gives full-year outlook, range above estimates * Dow up 0.9 pct, S&P up 1.2 pct, Nasdaq up 1.9 pct (Updates to midday, adds byline) NEW YORK, April 22...

NEW YORK, March 12 - U.S. stock index futures sharply cut losses on Thursday as news of a proposed takeover in the biotechnology sector tempered caution before data that investors fear may show more weakness...

* Pill would contain TMC278 and Truvada * Gilead to lead commercialization efforts * TMC278 sold to Gilead at up to 30 percent discount (Adds analyst comments, financial details, share prices, byline) LOS ANGELES, July...

* Net profit 72 cents/share beats 67 cents/share estimate * Revenue increases 31 pct to $1.8 billion * Shares fall 2.3 percent (Recasts, adds company comments, updates stock price) LOS ANGELES, Oct 20 - Gilead...

* Pill would contain TMC278 and Truvada * Gilead to lead commercialization efforts * Gilead gets up to 30 percent discount on TMC278 * Gilead shares rise 2.4 percent (Adds company comments, updates share prices)...